Literature DB >> 22160450

Paraoxonase 1 activity in chylomicrons and VLDL: the effect of type 2 diabetes and meals rich in saturated fat and oleic acid.

Patrick J Manning1, Sylvia A de Jong, Anne R Ryalls, Wayne H F Sutherland.   

Abstract

Paraoxonase 1 (PON 1) has antioxidant and cardioprotective properties and is abnormally low in type 2 diabetic serum. This study aimed to determine the effect of type 2 diabetes and meals rich in saturated fat and oleic acid on PON1 activity in chylomicrons and very low density lipoproteins (VLDL). PON1 arylesterase activity was measured in chylomicrons and VLDL that were isolated in serum from 20 patients with type 2 diabetes and 20 age- and gender-matched, overweight controls 3 h after meals rich in cream or olive oil in a randomized, cross-over study. Chylomicron-PON1 activity (45%, P = 0.02), ratio chylomicron-PON1/chylomicron-triacylglycerides (TAG) (42%, P = 0.03) and chylomicron-protein content (46%, P < 0.001) were significantly lower in patients with type 2 diabetes compared with controls after the olive oil meal with comparable findings after the meal rich in cream. After ingestion of olive oil, chylomicron-PON1 activity was significantly higher in controls (P = 0.01) and marginally higher (P = 0.06) in diabetic patients and chylomicron-TAG were significantly (P < 0. 05) higher in both groups of subjects, compared with values after ingestion of cream. VLDL-PON1 increased (two-fold) significantly (P < 0.003) during both meals. Chylomicron-PON1 activity was correlated significantly with chylomicron-protein (P < 0.001, n = 40) and with postprandial serum PON1 activity (P ≤ 0.001, n = 40). Our data suggest that type 2 diabetes is associated with abnormally low chylomicron-PON1 activity after fatty meals and this may be linked to lower chylomicron-protein content and serum PON1 activity. Switching from saturated fat to olive oil in the meal increases PON1 activity in the chylomicron fraction largely due to increased numbers of chylomicron particles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160450     DOI: 10.1007/s11745-011-3640-3

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  38 in total

Review 1.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Authors:  Lucio G Costa; Gennaro Giordano; Clement E Furlong
Journal:  Biochem Pharmacol       Date:  2010-11-18       Impact factor: 5.858

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.

Authors:  Maria Mastorikou; Mike Mackness; Bharti Mackness
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

4.  Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation.

Authors:  H Jakubowski
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

5.  Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.

Authors:  R C Sorenson; C L Bisgaier; M Aviram; C Hsu; S Billecke; B N La Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

6.  Dietary fat modulates serum paraoxonase 1 activity in rats.

Authors:  B J Kudchodkar; A G Lacko; L Dory; T V Fungwe
Journal:  J Nutr       Date:  2000-10       Impact factor: 4.798

7.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

Authors:  S L Primo-Parmo; R C Sorenson; J Teiber; B N La Du
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

8.  Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties.

Authors:  Orit Rozenberg; Maayan Shiner; Michael Aviram; Tony Hayek
Journal:  Free Radic Biol Med       Date:  2008-03-08       Impact factor: 7.376

9.  Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization.

Authors:  Su Duy Nguyen; Dai-Eun Sok
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

Review 10.  Adherence to Mediterranean diet and health status: meta-analysis.

Authors:  Francesco Sofi; Francesca Cesari; Rosanna Abbate; Gian Franco Gensini; Alessandro Casini
Journal:  BMJ       Date:  2008-09-11
View more
  3 in total

Review 1.  PON1 and Mediterranean Diet.

Authors:  José M Lou-Bonafonte; Clara Gabás-Rivera; María A Navarro; Jesús Osada
Journal:  Nutrients       Date:  2015-05-27       Impact factor: 5.717

Review 2.  Therapeutic Properties and Use of Extra Virgin Olive Oil in Clinical Nutrition: A Narrative Review and Literature Update.

Authors:  Andrés Jiménez-Sánchez; Antonio Jesús Martínez-Ortega; Pablo Jesús Remón-Ruiz; Ana Piñar-Gutiérrez; José Luis Pereira-Cunill; Pedro Pablo García-Luna
Journal:  Nutrients       Date:  2022-03-31       Impact factor: 5.717

Review 3.  Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?

Authors:  Estefania Gastaldello Moreira; Karine Maria Boll; Dalmo Guilherme Correia; Janaina Favaro Soares; Camila Rigobello; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.